Maximus, Inc. (MMS) to Issue Quarterly Dividend of $0.30 on February 29th

Maximus, Inc. (NYSE:MMSGet Free Report) declared a quarterly dividend on Thursday, January 11th, Wall Street Journal reports. Shareholders of record on Thursday, February 15th will be given a dividend of 0.30 per share by the health services provider on Thursday, February 29th. This represents a $1.20 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date is Wednesday, February 14th.

Maximus has increased its dividend payment by an average of 0.6% per year over the last three years and has increased its dividend annually for the last 1 consecutive years. Maximus has a dividend payout ratio of 21.6% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Maximus to earn $5.70 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 21.1%.

Maximus Trading Up 4.8 %

MMS opened at $82.57 on Monday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69. The company’s 50 day simple moving average is $82.24 and its two-hundred day simple moving average is $80.02. Maximus has a 1-year low of $72.39 and a 1-year high of $89.69. The firm has a market capitalization of $5.04 billion, a price-to-earnings ratio of 27.34 and a beta of 0.72.

Maximus (NYSE:MMSGet Free Report) last released its earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.06. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period last year, the company posted $0.94 EPS. The business’s revenue was up 6.2% on a year-over-year basis. Analysts expect that Maximus will post 5.36 EPS for the current fiscal year.

Wall Street Analyst Weigh In

MMS has been the topic of a number of research reports. TheStreet raised shares of Maximus from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Raymond James downgraded shares of Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd.

Read Our Latest Research Report on MMS

Insider Transactions at Maximus

In other news, insider Ilene R. Baylinson sold 10,043 shares of the firm’s stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $85.57, for a total transaction of $859,379.51. Following the completion of the sale, the insider now owns 5,002 shares in the company, valued at approximately $428,021.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.40% of the company’s stock.

Institutional Trading of Maximus

Several institutional investors have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC increased its holdings in Maximus by 8,288.2% in the 4th quarter. International Assets Investment Management LLC now owns 1,426 shares of the health services provider’s stock valued at $120,000 after purchasing an additional 1,409 shares during the last quarter. Toroso Investments LLC acquired a new stake in Maximus in the 3rd quarter valued at approximately $265,000. Stifel Financial Corp increased its holdings in Maximus by 3.6% in the 3rd quarter. Stifel Financial Corp now owns 11,152 shares of the health services provider’s stock valued at $833,000 after purchasing an additional 391 shares during the last quarter. Teachers Retirement System of The State of Kentucky increased its holdings in Maximus by 10.1% in the 2nd quarter. Teachers Retirement System of The State of Kentucky now owns 10,897 shares of the health services provider’s stock valued at $921,000 after purchasing an additional 997 shares during the last quarter. Finally, Nuveen Asset Management LLC increased its holdings in Maximus by 36.5% in the 2nd quarter. Nuveen Asset Management LLC now owns 543,289 shares of the health services provider’s stock valued at $45,913,000 after purchasing an additional 145,223 shares during the last quarter. Institutional investors and hedge funds own 99.30% of the company’s stock.

About Maximus

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Dividend History for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.